-
Generation and characterization of rendomab-B1, a monoclonal antibody display...
International audience -
Study of the neutralizing antibody response against the hepatitis C virus
Hepatitis C Virus (HCV) is the major etiological agent of liver disease in the world with approximately180 million people who are seropositive. The majority (60‐90%)... -
Cross-species reactivity of seven monoclonal antibodies with equine lymphocyt...
International audience -
Characterization of a novel activation antigen on porcine lymphocytes recogni...
International audience -
Membrane markers of the immune cells in swine: an update
International audience -
Expression of toll-like receptor 2 (TLR2) in porcine leukocyte subsets and ti...
International audience -
Targeting to porcine sialoadhesin receptor improves antigen presentation to T...
International audience -
Immunotherapies of hepatocellular carcinoma and hepatitis C virus infection
The hepatitis C virus (HCV) is a major cause of hepatocellular carcinoma (HCC),whose treatments are of limited efficacy. The liver transplantation (LT) is the optimal... -
Use of a monoclonal antibody anti-Tn in cancer immunotherapy
Pas de résumé en anglais -
Preparation and characterization of a human aurora-A kinase monoclonal antibody.
International audience -
ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab nasal ...
International audience -
Functional study of oncogenic KIT : new strategies for selective oncogenic KI...
When overexpressed or constitutively active by mutation, the tyrosine kinase receptor KIT is involved in some proliferative diseases such as gastro-intestinal stromal...
